ArticleJournal of experimental & clinical cancer research : CR2018

miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2).

Xi He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.